MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.

MLA

Tang, Yen-An, et al. “MDM2 Overexpression Deregulates the Transcriptional Control of RB/E2F Leading to DNA Methyltransferase 3A Overexpression in Lung Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 18, no. 16, Aug. 2012, pp. 4325–33. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-11-2617.

APA

Tang, Y.-A., Lin, R.-K., Tsai, Y.-T., Hsu, H.-S., Yang, Y.-C., Chen, C.-Y., & Wang, Y.-C. (2012). MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(16), 4325–4333. https://doi.org/10.1158/1078-0432.CCR-11-2617

Chicago

Tang, Yen-An, Ruo-Kai Lin, Yo-Ting Tsai, Han-Shui Hsu, Yi-Chieh Yang, Chih-Yi Chen, and Yi-Ching Wang. 2012. “MDM2 Overexpression Deregulates the Transcriptional Control of RB/E2F Leading to DNA Methyltransferase 3A Overexpression in Lung Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 18 (16): 4325–33. doi:10.1158/1078-0432.CCR-11-2617.